Skip to main content
Caplight Logo









Respiray

Respiray

Private
TallinnConsumer & Commercehttps://respiray.com

Last Round

Grant

Feb 9, 2022

Total Funding Raised

$2.11M

Company Overview

Respiray operates in Consumer & Commerce and is based in Tallinn. Its latest recorded funding round was a Grant round in February 2022.

Respiray is a health technology company that designs and manufactures wearable air purification devices for allergy and respiratory protection.

Sector

Consumer & Commerce

Verticals

Consumer Electronics, Medical Devices, D2C Brands, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Respiray Comparables

Compare Respiray with similar companies based on industry and business-model similarity.

Respiray comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aō Air
89%
ible Technology Inc.
84%
Blue Sky Labs
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Respiray Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 9, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Karl Gustav Annus

Chief Executive Officer

Executive Team

Karl Madis Sutter

CEO

Executive Team

For institutional investors. Book with your work email.

Respiray Investors

Notable investors and investment history

Respiray investors
InvestorRounds
Metaplanet HoldingsSeed
Enterprise EstoniaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 54% MoM.

  • Jun 1, 2025

    Monthly visitors increased 45% MoM, reaching 15.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Respiray Filings

Explore SEC and related filing metadata, where available.

Respiray filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Respiray's valuation, stock price, and market status.

Is Respiray a public or private company?

Respiray is a private company.

What is the current stock price of Respiray?

Respiray is a private company, so its shares have no public market price. Caplight tracks Respiray's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Respiray worth (valuation)?

Valuation information for Respiray is not publicly available.

Can I buy Respiray stock?

Respiray shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Respiray's last funding round?

Respiray's most recent funding round was Grant on February 9, 2022.

Who are the main investors in Respiray?

Key investors in Respiray include Metaplanet Holdings, Enterprise Estonia.

Will Respiray IPO soon?

No public IPO plans have been announced for Respiray.

How can I track Respiray secondary market activity?

Caplight tracks bids, offers, and trades in Respiray's shares on secondary markets.

Firmographic Details

HeadquartersTallinn
Employee Range6
Year Founded2020
Last FundingFeb 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?